78 related articles for article (PubMed ID: 21222333)
1. [Osteoporosis. Improving bone and muscle performance].
MMW Fortschr Med; 2010 Dec; 152(48):36. PubMed ID: 21222333
[No Abstract] [Full Text] [Related]
2. Potency of a combined alfacalcidol-alendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoid-induced osteoporosis.
Ringe JD; Schacht E; Dukas L; Mazor Z
Arzneimittelforschung; 2011; 61(2):104-11. PubMed ID: 21428245
[TBL] [Abstract][Full Text] [Related]
3. Risk reduction of falls and fractures, reduction of back pain and safety in elderly high risk patients receiving combined therapy with alfacalcidol and alendronate: a prospective study.
Schacht E; Ringe JD
Arzneimittelforschung; 2011; 61(1):40-54. PubMed ID: 21355445
[TBL] [Abstract][Full Text] [Related]
4. Potential of alfacalcidol for reducing increased risk of falls and fractures.
Ringe JD; Schacht E
Rheumatol Int; 2009 Aug; 29(10):1177-85. PubMed ID: 19159932
[TBL] [Abstract][Full Text] [Related]
5. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
Kishimoto M; Oishi A; Motojima S
N Engl J Med; 2006 Nov; 355(20):2156; author reply 2157. PubMed ID: 17108350
[No Abstract] [Full Text] [Related]
6. Safety of bisphosphonates in women of child bearing age.
McKenna M; Mansfield JC
Aliment Pharmacol Ther; 2009 Jun; 29(11):1214-5; author reply 1215-6. PubMed ID: 19473128
[No Abstract] [Full Text] [Related]
7. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
Minisola S; Scillitani A; Romagnoli E
N Engl J Med; 2006 Nov; 355(20):2156-7; author reply 2157. PubMed ID: 17120352
[No Abstract] [Full Text] [Related]
8. Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass.
Schacht E; Ringe JD
Rheumatol Int; 2012 Jan; 32(1):207-15. PubMed ID: 20827552
[TBL] [Abstract][Full Text] [Related]
9. [Drug therapy for prevention of falls and fractures].
Ringe JD
Med Klin (Munich); 2006 Jun; 101 Suppl 1():1-5. PubMed ID: 16826362
[TBL] [Abstract][Full Text] [Related]
10. Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.
Orimo H; Nakamura T; Fukunaga M; Ohta H; Hosoi T; Uemura Y; Kuroda T; Miyakawa N; Ohashi Y; Shiraki M;
Curr Med Res Opin; 2011 Jun; 27(6):1273-84. PubMed ID: 21554143
[TBL] [Abstract][Full Text] [Related]
11. Treatment of renal transplant recipients with low bone mineral density: a randomized prospective trial of alendronate, alfacalcidol, and alendronate combined with alfacalcidol.
Trabulus S; Altiparmak MR; Apaydin S; Serdengecti K; Sariyar M
Transplant Proc; 2008; 40(1):160-6. PubMed ID: 18261575
[TBL] [Abstract][Full Text] [Related]
12. Effect of a six-month therapy with alfacalcidol on muscle power and balance and the number of fallers and falls.
Dukas L; Schacht E; Runge M; Ringe JD
Arzneimittelforschung; 2010; 60(8):519-25. PubMed ID: 20863009
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol].
Ziegler R
Med Monatsschr Pharm; 2007 Mar; 30(3):122-3. PubMed ID: 17405496
[No Abstract] [Full Text] [Related]
14. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.
Schacht E; Richy F; Reginster JY
J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518
[TBL] [Abstract][Full Text] [Related]
15. The role of alendronate in mitigating perimenopausal bone loss: a double-blind randomized controlled pilot study.
Mersereau JE; Khouri C; Jaffe RB
Fertil Steril; 2010 Aug; 94(3):1138-40. PubMed ID: 20056199
[TBL] [Abstract][Full Text] [Related]
16. [Treating with what? Therapy for how long?].
MMW Fortschr Med; 2005 Dec; 147(51-52):62-3. PubMed ID: 16402713
[No Abstract] [Full Text] [Related]
17. [Effect of alendronate on glucocorticoid-induced osteoporosis].
Zou X; Li Q; Shi C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):563-5. PubMed ID: 19587443
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis.
Kitazaki S; Mitsuyama K; Masuda J; Harada K; Yamasaki H; Kuwaki K; Takedatsu H; Sugiyama G; Tsuruta O; Sata M
Aliment Pharmacol Ther; 2009 Feb; 29(4):424-30. PubMed ID: 19035979
[TBL] [Abstract][Full Text] [Related]
19. Renal function and bisphosphonate safety.
Ott SM; Drueke T; Elder G; Fukagawa M; Jorgetti V; Langman CB; Moe S; McCann L; Wang AY; Weisinger J; Wheeler D
J Bone Miner Res; 2008 Mar; 23(3):453-4; author reply 455. PubMed ID: 17967135
[No Abstract] [Full Text] [Related]
20. [D-hormone reduces rate of falls. In osteoporosis consider more than bone density].
MMW Fortschr Med; 2002 Dec; 144(49):58. PubMed ID: 12577745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
